The workup of Autoimmune ILD for APPs is an important aspect of the assessment of interstitial lung disease related to connective tissue disease which involves differentiating inflammatory patterns and possibly... Read More
Author: ILD
In the Interstitial Lung Disease MDD model, the APP's role encompasses accurate diagnosis, organized case management, and the development of evidence-based plans for complex inflammatory and fibrotic lung disease. MDD... Read More
Symptom management and palliative care in ILD for APPs is particularly essential in interstitial lung disease care in the progressive and fibrotic stages where symptom burden is life limiting. Interstitial... Read More
As new therapies and diagnostic innovations are introduced, the management of interstitial lung Disease continues to change, elevating the importance of ILD Clinical Trials and Research Roles for APPs. Clinical... Read More
The care of advanced practice providers in hypersensitivity pneumonitis (HP) involves detailed exposure assessment, precise diagnostic undertakings, comprehensive management, and established longitudinal observations HP (Hypersensitivity Pneumonitis) is an immune mediated... Read More
Rheumatology-pulmonology collaboration for APPs is pivotal for the provision of integrated and added-value services for patients suffering from autoimmune and connective tissue-related interstitial lung disease (ILD). A substantial number of... Read More
The APP guide to Interpretation of Pulmonary Function Tests (PFT) is key when evaluating and continuously monitoring interstitial lung disease (ILD). Pulmonary function tests provide objective and reproducible data to... Read More
Integrating Advanced Practice Providers (APPs) in ILD care coordination and navigation is vital to managing the progressive, complex, and often multisystem nature of interstitial lung disease (ILD). Advanced Practice Providers... Read More
Management of antifibrotic therapies by advanced practice providers is of great importance in the management of interstitial lung disease (ILD), specifically in patients with idiopathic pulmonary fibrosis (IPF) and those... Read More
A significant part of the evaluation and diagnosis of interstitial lung disease (ILD) includes the interpretation of the HRCT scan by advanced practice providers (APP). The high-resolution computed tomography (HRCT)... Read More